ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,106Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 2456

$772K Total Retail Price of All Prescriptions

Rank: 83 out of 2456

410 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 14,726 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,236 1,236 1 9
FUROSEMIDE 622 622 2 8
LEVOTHYROXINE SODIUM 600 578 3 4
SIMVASTATIN 599 583 4 2
ATENOLOL 541 537 5 6
TRAZODONE HCL 513 493 6 17
LISINOPRIL 442 437 7 1
AMLODIPINE BESYLATE 350 348 8 5
METOPROLOL TARTRATE 318 318 9 10
OMEPRAZOLE 310 310 10 3
ATORVASTATIN CALCIUM 303 293 11 12
DONEPEZIL HCL 270 259 12 23
POTASSIUM CHLORIDE 238 238 13 33
CITALOPRAM HBR 228 228 14 14
METFORMIN HCL 220 192 15 11
NAMENDA 212 200 16 42
HYDROCHLOROTHIAZIDE 209 209 17 7
METOPROLOL SUCCINATE 208 208 18 13
MIRTAZAPINE 185 185 19 29
GABAPENTIN 160 160 20 16
TRIAMTERENE-HCTZ 145 133 21 53
CLOZAPINE 137 61 22 75
SERTRALINE HCL 136 136 23 21
OLANZAPINE 135 135 24 57
DIVALPROEX SODIUM 133 133 25 51
GLIPIZIDE 126 113 26 46
TRAMADOL HCL 126 126 26 24
CARBIDOPA-LEVODOPA 119 119 28 82
NIFEDIPINE ER 117 113 29 61
ENALAPRIL MALEATE 112 110 30 70
RANITIDINE HCL 111 96 31 31
ALLOPURINOL 107 105 32 27
ALENDRONATE SODIUM 106 106 33 19
QUETIAPINE FUMARATE 105 105 34 47
LOSARTAN POTASSIUM 105 102 34 18
LACTULOSE 104 104 36 88
DIOVAN 102 102 37 26
LIDODERM 97 97 38 58
HYDRALAZINE HCL 92 92 39 105
LIPITOR 90 85 40 63
TAMIFLU 86 85 41 217
VESICARE 84 84 42 205
DILTIAZEM 24HR CD 72 72 43 113
PREDNISONE 71 70 44 39
DIGOXIN 70 70 45 49
HYDROCODONE-ACETAMINOPHEN 66 61 S3 46 20
LATANOPROST 65 65 47 156
RISPERIDONE 65 65 47 50
CARBAMAZEPINE 65 65 47 155
HUMULIN N 63 63 50 187
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 62 51 147
TAMSULOSIN HCL 61 61 52 32
EVISTA 61 61 52 143
PRAVASTATIN SODIUM 57 57 54 15
ADVAIR DISKUS 57 56 54 36
ZOLPIDEM TARTRATE 56 56 56 28
NEXIUM 56 56 56 80
PAROXETINE HCL 53 53 58 56
AMOXICILLIN 52 52 59 191
ISOSORBIDE MONONITRATE ER 51 51 60 48
FLUTICASONE PROPIONATE 50 46 61 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.